The CRC/TRR 417 "Cellular Communication in the Stroma of Colorectal Cancer: From Pathophysiology to Clinical Translation”, focusing on understanding and therapeutically targeting the tumor microenvironment in colorectal cancer was granted to Goethe University Frankfurt, together with Friedrich-Alexander University Erlangen-Nürnberg and the University of Freiburg by the DFG earlier this year. This interdisciplinary research consortium aims to overcome resistance to immunotherapies by reprogramming stromal and immune cells and integrating insights from the gut microbiome.
We are seeking 30 Doctoral Candidates (m/f/d) to join the TRR 417 on all three sites, pursuing functional cancer research on different aspects of cellular communication in the tumor microenvironment of colorectal cancer.
The positions are integrated into the structured education program of the Integrated Research Training Group (IRTG) and provide ample networking opportunities amongst the doctoral candidates as well as with the more established researchers in the TRR 417. The IRTG sets out to educate tomorrow’s specialists in academic research, clinical practice and pharmaceutical industry that work towards improving the life quality and expectancy of CRC patients.
The participating laboratories cover a broad range of unique and complementing expertise. They offer a variaty of different projects ranging from the role of CAFs, vascular cells or the extracellular matrix, to soluble mediators and the microbiome to immune cells in colorectal cancer.
Visit https://trr417.de to read more about the particular projects.
Applications should be submitted electronically to career@trr417.de
as a single PDF file containing:
Georg-Speyer-Haus
Paul-Ehrlich-Str. 42-44 | 60596 Frankfurt/Main
The CRC/TRR 417 Cellular Communication in the Stroma of Colorectal Cancer From Pathophysiology to Clinical Translation, focusing on understanding and therapeutically targeting the tumor microenvironment in colorectal cancer was granted to Goethe University Frankfurt, together with ...
Erstellt am 23.08.2025 von Georg-Speyer-Haus Institut für Tumorbiologie und Experimentelle Therapie
Arbeitsort 60311 Frankfurt am Main
Das Georg-Speyer-Haus in Frankfurt am Main ist eine private Stiftung und betreibt als Institut für Tumorbiologie und Experimentelle Therapie international kompetitive, onkologisch ausgerichtete Forschung mit einem besonderen Schwerpunkt auf dem Tumor Microenvironment TME, mit dem Ziel die ...
Erstellt am 18.07.2025 von Georg-Speyer-Haus Institut für Tumorbiologie und Experimentelle Therapie
Arbeitsort 60311 Frankfurt am Main
The Georg-Speyer-Haus in Frankfurt am Main, Institute for Tumor Biology and Experimental Therapy, is an academic non-profit research institute supported by the Federal Ministry of Health and the Hessian Ministry of Science and Research, Arts and Culture. The institute is dedicated to basic and ...
Erstellt am 27.06.2025 von Georg-Speyer-Haus Institut für Tumorbiologie und Experimentelle Therapie
Arbeitsort 60311 Frankfurt am Main